Skip to main content
Premium Trial:

Request an Annual Quote

Peter Jensen, Whaijen Soo, Bob Hamm


Peter Jensen has become a non-executive director of New Milton, UK-based Genetix. He is currently chairman of the European Business Forum, a non-executive director of Domino Printing Sciences, and a non-executive of Newmarket Racecourses Trust. Prior to that, he was a member of the GlaxoSmithKline integration planning committee, president of SmithKlineBeecham’s worldwide supply operations, and chairman of SmithKlineBeecham’s European consumer healthcare operations.

Genetix supplies automated systems and services for genomic and proteomic research.


Whaijen Soo has been appointed senior vice president for medical research at Biogen, based in Cambridge, Mass. He will oversee all medical research activities and will serve as a member of the research and development management team. He most recently served as vice president for clinical sciences at Roche. Soo holds a BS in Chemistry from the National Taiwan University and a PhD in Biochemistry from the University of California at Berkeley. He attended medical school at the University of California at San Francisco and did his residency at Brigham and Woman’s Hospital, Harvard Medical School.


Biogen also named Bob Hamm senior vice president of North American commercial operations. In this newly created position, Hamm will oversee Biogen’s US neurology and dermatology business units, US commercial services, and Canadian operations. Hamm joined Biogen in 1994 as associate director for logistics and has served in various positions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.